Search Results 3021-3030 of 25704 for oral
Evaluate clinical effectiveness of oral montelukast compared to placebo on prevention of dysphagia and food impaction in patients with EE. Also evaluate ...
... oral therapy) for 90 days prior to Baseline. Subject has pulmonary veno-occlusive disease. Malignancy diagnosed and/or treated within 5 years prior to ...
Improved oral and written communication skills facilitate success in competitive graduate student fellowship applications, Ph.D. qualifying exams, and later ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... oral opioids, and increased patient satisfaction. There are no reports of the use of Exparel in the ophthalmic literature. The investigators propose a ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%. Stabilized patients on oral hypoglycemic ...
... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...
Oral Cavity Cancer and Reconstruction Clinic in Minnesota. Location. Rochester, Minnesota. Languages. English. Existing patients. Send a secure message via ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.